title: Effect of ppMCH derived peptides on PBMC proliferation and cytokine expression.
abstract: The mRNA encoding prepro-Melanin concentrating hormone (ppMCH) is mainly expressed in the central nervous system but has also been detected at lower amount in many peripheral tissues including spleen and thymus. At the peptide level however, several forms of the precursor can be detected in these tissues and are sometimes expressed at similar levels compared to brain. In the present work, we have studied the in vitro action of a wide range of concentration (1 nM to 1 microM) of the different peptides encoded by ppMCH i.e. neuropeptide glycine-glutamic acid (NGE), neuropeptide glutamic acid-isoleucine (NEI), Melanin concentrating hormone (MCH) and the dipeptide NEI-MCH on peripheral blood mononuclear cells (PBMC) proliferation and cytokine production following anti-CD3 stimulation. Among them only MCH decreased PBMC proliferation with a maximal effect of 35% at 100 nM. Moreover as demonstrated by using ELISA, MCH significantly decreases IL-2 production by 25% but not IL-4, INF-gamma or TNF-alpha expression. Interestingly, exogenous IL-2 decreases significantly MCH-mediated inhibition, suggesting that it is an important downstream mediator of MCH action. Finally, we showed that after 7 to 9 days of incubation, MCH also inhibits proliferation of non-stimulated PBMC. Altogether, these data demonstrate that fully mature MCH modulates proliferation of anti-CD3 stimulated PBMC partially through regulation of IL-2 production.
authors.affiliation: Center for Cellular and Molecular Neurobiology, University of Liège, Liège, Belgium.
authors.forename: Bernard
authors.initials: B
authors.lastname: Coumans
authors.forename: Thierry
authors.initials: T
authors.lastname: Grisar
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Nahon
authors.forename: Bernard
authors.initials: B
authors.lastname: Lakaye
mesh_terms: D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D007028:Hypothalamic Hormones / Q000494:pharmacology*; D007371:Interferon-gamma / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism / Q000494:pharmacology; D015847:Interleukin-4 / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008543:Melanins / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology; D010907:Pituitary Hormones / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016207:Cytokines; D007028:Hypothalamic Hormones; D007376:Interleukin-2; D008543:Melanins; D010446:Peptide Fragments; D010907:Pituitary Hormones; D014409:Tumor Necrosis Factor-alpha; C075862:melanin-concentrating-hormone precursor (129-145)-glutamyl-isoleucinamide; D015847:Interleukin-4; C019463:melanin-concentrating hormone; D007371:Interferon-gamma